Back
REX American Resources Vs. Novartis AG Industry Stock Comparison
Sell
38
REX
REX American Resources
Last Price:
$39.75
Seasonality Move:
7.56%
Buy
59
NVSEF
Novartis AG
Last Price:
$107.55
Seasonality Move:
5.97%
Sell
38
REX American Resources (REX)
is a Sell
Is REX American Resources a Buy, Sell or Hold?
-
The current REX American Resources [REX] share price is $38.61. The Score for REX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
REX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $107.55. The Score for NVSEF is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
REX Stock Price Chart
What is REX American Resources's stock price today?
-
The REX American Resources share price today is $38.61Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REX is experiencing slight selling pressure.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $107.55Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVSEF is experiencing slight buying pressure.
REX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.88 | Sell |
| Relative Strength Index (14 RSI): | 54.6 | Buy |
| Chaikin Money Flow: | -81047 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.84 - 40.22) | Buy |
| Bollinger Bands (100): | (38.69 - 44.91) | Sell |
NVSEF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.55 | Buy |
| Relative Strength Index (14 RSI): | 45.62 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (107.25 - 114.29) | Sell |
| Bollinger Bands (100): | (98.5 - 109.54) | Buy |
REX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.91 | Buy |
| 20-day SMA: | 37.08 | Buy |
| 50-day SMA: | 39.99 | Sell |
| 200-day SMA: | 43.69 | Sell |
| 8-day EMA: | 37.13 | Buy |
| 20-day EMA: | 37.64 | Buy |
| 50-day EMA: | 39.38 | Sell |
| 200-day EMA: | 42.78 | Sell |
NVSEF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 111.73 | Sell |
| 20-day SMA: | 111.57 | Sell |
| 50-day SMA: | 106.51 | Buy |
| 200-day SMA: | 106.88 | Buy |
| 8-day EMA: | 111.99 | Sell |
| 20-day EMA: | 110.88 | Sell |
| 50-day EMA: | 107.89 | Sell |
| 200-day EMA: | 104.88 | Buy |
REX American Resources Earnings Growth & REX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.24 per share, an increase this year of $0.01 per share, and a decrease next year of $1.48 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
REX American Resources Technical Analysis
| Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novartis AG Technical Analysis
| Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||